Advertisement

 

 

Metabolic Complications among Korean Patients with HIV Infection: The Korea HIV/AIDS Cohort Study.

Metabolic Complications among Korean Patients with HIV Infection: The Korea HIV/AIDS Cohort Study.
Author Information (click to view)

Oh DH, Ahn JY, Kim SI, Kim MJ, Woo JH, Kim WJ, Baek JH, Kim SW, Choi BY, Lee MH, Choi JY, Han MG, Kang C, Kim JM, Choi JY, ,


Oh DH, Ahn JY, Kim SI, Kim MJ, Woo JH, Kim WJ, Baek JH, Kim SW, Choi BY, Lee MH, Choi JY, Han MG, Kang C, Kim JM, Choi JY, , (click to view)

Oh DH, Ahn JY, Kim SI, Kim MJ, Woo JH, Kim WJ, Baek JH, Kim SW, Choi BY, Lee MH, Choi JY, Han MG, Kang C, Kim JM, Choi JY, ,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Journal of Korean medical science 32(8) 1268-1274 doi 10.3346/jkms.2017.32.8.1268

Abstract

Currently, metabolic complications are the most common problem among human immunodeficiency virus (HIV)-infected patients, with a high incidence. However, there have been very few studies regarding metabolic abnormalities published in Asia, especially in Korea. This cross-sectional study was performed to investigate the prevalence of and risk factors for metabolic abnormalities in 1,096 HIV-infected patients of the Korea HIV/AIDS cohort study enrolled from 19 hospitals between 2006 and 2013. Data at entry to cohort were analyzed. As a result, the median age of the 1,096 enrolled subjects was 46 years, and most patients were men (92.8%). The metabolic profiles of the patients were as follows: median weight was 63.8 kg, median body mass index (BMI) was 22.2 kg/m², and 16.4% of the patients had a BMI over 25 kg/m². A total of 5.5% of the patients had abdominal obesity (waist/hip ratio ≥ 1 in men, ≥ 0.85 in women). Increased levels of fasting glucose, total cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides were present in 10.4%, 6.0%, 5.5%, and 32.1% of the patients. Decreased high-density lipoprotein (HDL) cholesterol levels were observed in 44.2% of the patients. High systolic blood pressure was present in 14.3% of the patients. In multivariate analysis, high BMI and the use of protease inhibitors (PIs) were risk factors for dyslipidemia in HIV-infected patients. In conclusion, proper diagnosis and management should be offered for the prevalent metabolic complications of Korean HIV-infected patients. Further studies on risk factors for metabolic complications are needed.

Submit a Comment

Your email address will not be published. Required fields are marked *

13 − 11 =

[ HIDE/SHOW ]